-13 In CCA, miR-641 was identified as the suppressor of cancer growth and metastasis that could inhibit the expression of CDR1 Antisense RNA (CDR1as), Akt serine/threonine kinase 3 (AKT3), and mammalian target of rapamycin (mTOR).14 Here, LINC00632 is linked to cholangiocarcinoma.